Current Opinion in Infectious Diseases

Article	Citations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	63
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	58
Surgical management of cystic echinococcosis of the liver	57
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma	50
Corticosteroids for viral central nervous system infections	48
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	45
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	43
Complexities of cardiomyopathy in septic shock	41
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	38
Strongyloidiasis-related lung involvement: too much of a bad thing	33
Skin and soft tissue infections in the elderly	33
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	32
La Crosse virus encephalitis in children	32
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	31
Viral meningitis and encephalitis: an update	30
Typhoid fever control in the 21st century: where are we now?	30
Tissue resident memory T cells in respiratory infections	30
Managing cognitive impairment in people with HIV: Erratum	30
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	29
Fusarium species central nervous system infection	28
Tuberculosis molecular bacterial load assay in the management of tuberculosis	27
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	26
Mpox in people living with HIV	26
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	24
Malaria in pregnancy: baby steps	23

Tropical infectious diseases and skin manifestations: a diagnostic framework	23
Resistant herpes simplex virus infections – who, when, and what's new?	23
Tick-borne encephalitis	22
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	21
Does climate change threaten delivery of HIV care in resource-limited settings?	21
Appropriate surgical management in skin and soft tissue infections	20
Editorial introductions	20
Diagnostic stewardship: what impacts antibiotics use?	19
Using antibiotics wisely	18
Interventions for polyoma virus-associated hemorrhagic cystitis	18
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	17
Diagnostic approach and update on encephalitis	17
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease	17
CMV antiviral stewardship in transplantation – the next frontier	17
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	16
Update on the treatment of chronic pulmonary aspergillosis	16
Recent advances in flavivirus encephalitis	16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	16
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	16
Gut microbiome and its clinical implications: exploring the key players in human health	16
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	16
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	15
Editorial introductions	15
The microbiota in respiratory tract infections: from association to intervention	15
The plumbing problem: rising antimicrobial resistance in building water systems	15
Editorial: Pathogenesis and immune response – editorial	14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics	14
Childhood tuberculosis	14
Interpreting and managing preservation fluids positive for Gram-negative bacteria	14
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	14
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	13
Data science for pediatric infectious disease: utilizing COVID-19 as a model	13
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	13
Travellers’ diarrhoea – solidifying our knowledgebase	13
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	13
An overview of risk factors, management and prevention of cochlear implant infections	13
Antiviral therapies for respiratory syncytial virus infection: current expectations	12
The disease burden of respiratory syncytial virus in Infants	12
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
The microbiome as a biomarker of anal precancerous lesions in people with HIV	12
Short treatment duration for community-acquired pneumonia	11
Respiratory metagenomics: route to routine service	11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	11
Genetic mechanisms underlying host susceptibility to central nervous system viral infections	11
Advanced neuroimaging for central nervous system infections: when, where, how, and why?	11
Update on drug treatments for multidrug resistant tuberculosis	11

Identifying patients with difficult-to-treat acute bacterial skin infections	11
Chronic persistent Norovirus in the immune-compromised host	11
Urinary tract infections in immunocompromised patients	10
Anti-inflammatory therapies for bronchiectasis	10
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	10
Skin and soft tissue infections in solid organ transplants	10
Neurobrucellosis	10
Burden of influenza in the elderly: a narrative review	10
Updates on the neurological manifestations of SARS-CoV-2 infection	10
A new era of HIV care for age-associated multimorbidity	10
Short-course antibiotic strategies for ventilator-associated pneumonia	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
Immune responses and severe dengue: what have we learned?	10
The evolution of knowledge for treating Gram-negative bacterial infections	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Therapeutic agents for the treatment of human mpox	9
Surgical site infection prophylaxis: what have we learned and are we making progress?	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	9
Chagas disease in the immunocompromised host	9
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
Tropical gastrointestinal infections of contemporary public health importance	8
Management of nonfermenting gram-negative infections: a critique of the guidelines	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Eravacycline: from clinical trials to its potential place in everyday therapy	8
Editorial introductions	8
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	8
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Editorial introductions	8
The implications of the COVID-19 pandemic for long term care facilities	8
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	7
Pneumocystis jiroveci: still troublesome to diagnose and treat	7
An update on infectious encephalitis: from epidemiology to management	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Preventing respiratory viral transmission in healthcare settings	7
Long COVID in children and young people: then and now	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Recent advances in the management of skin and soft tissue infections	7
Antiviral therapies for influenza	7
Medical management of cystic echinococcosis	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Editorial introductions	7
Editorial introductions	7
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Human toxoplasmosis: current advances in the field	6
Editorial introductions	6
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?	6
Editorial introductions	6
The power of story: what Victorian novels can teach us about public health	6
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	6
Current status of primary, secondary and tertiary prevention of congenital cytomegalovirus disease: a call to action	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Risk factors for cognitive decline in persons with HIV	6
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	6
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	5
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	5
Viral infections and inborn errors of immunity	5
Current challenges in neurocysticercosis: recent data and where we are heading	5
Viral diarrheas – newer advances in diagnosis and management	5
Central nervous system infections in the tropics	5
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	5
Skin and soft tissue infections due to rapidly growing mycobacteria	5
Nontyphoidal Salmonella infections acquired from poultry	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
The microbiology and pathogenesis of nonfermenting Gram-negative infections	5
Brain abscess in immunocompetent patients: recent findings	5
Neutropenia and antibiotics: when, what, how and why?	5
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	5
Vitamin D for tuberculosis or acute respiratory infections: lost in translation?	5
Editorial introductions	5
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	5
Dengue encephalitis: what's new?	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worry	5

Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	5
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections	4
Hyperammonemia syndrome in immunosuppressed individuals	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	4
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	4
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	4
How to treat severe Acinetobacter baumannii infections	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
Host-directed immunotherapy for viral infections	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
NSAIDs for early management of acute respiratory infections	4
Updates on diagnosis and management of parasitic infections of the central nervous system	4
Editorial introductions	4
HIV and menopause: current evidence, gaps, and future directions for integrated care	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
Editorial introductions	4
Infant feeding: emerging concepts to prevent HIV transmission	4
Endemic mycoses – are we making progress in management?	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4